Boston Scientific/BSX

$67.79

-0.25%
-
1D1W1MYTD1YMAX

About Boston Scientific

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. The Cardiovascular segment includes Cardiology and Peripheral Interventions. The Company's Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions.

Ticker

BSX

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Michael Mahoney

Employees

48,000

Headquarters

Marlborough, United States

BSX Metrics

BasicAdvanced
$99.13B
Market cap
62.97
P/E ratio
$1.07
EPS
0.79
Beta
-
Dividend rate
$99.13B
0.79016
$69.21
$48.35
6.42M
1.32
0.817
44.451
47.205
53.091
5.16%
4.71%
8.53%
5.43%
62.966
6.961
5.126
56.196
12.29%
140.15%
12.83%

What the Analysts think about BSX

Analyst Ratings

Majority rating from 33 analysts.
Buy

Price Targets

Average projection from 29 analysts.
8.79% upside
High $81.00
Low $63.00
$67.79
Current price
$73.75
Average price target

BSX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
13.55% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$3.73B
5.61%
Net income
$505M
0%
Profit margin
13.55%
-5.31%

BSX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 7.37%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.47
$0.53
$0.50
$0.55
-
Expected
$0.44
$0.49
$0.48
$0.51
$0.51
Surprise
7.61%
8.27%
4.86%
7.37%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Boston Scientific stock?

Boston Scientific (BSX) has a market cap of $99.13B as of April 18, 2024.

What is the P/E ratio for Boston Scientific stock?

The price to earnings (P/E) ratio for Boston Scientific (BSX) stock is 62.97 as of April 18, 2024.

Does Boston Scientific stock pay dividends?

No, Boston Scientific (BSX) stock does not pay dividends to its shareholders as of April 18, 2024.

When is the next Boston Scientific dividend payment date?

Boston Scientific (BSX) stock does not pay dividends to its shareholders.

What is the beta indicator for Boston Scientific?

Boston Scientific (BSX) has a beta rating of 0.79. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Boston Scientific stock price target?

The target price for Boston Scientific (BSX) stock is $73.75, which is 8.78% above the current price of $67.8. This is an average based on projections from 29 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Boston Scientific stock

Buy or sell Boston Scientific stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing